documents: FDA-2007-D-0369-0554

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2007-D-0369-0554 FDA FDA-2007-D-0369 Product-Specific Guidance for Cilastatin Sodium; Imipenem; Relebactam; Draft Guidance for Industry; Availability Notice Notice of Availability 2021-07-19T04:00:00Z 2021 7 2021-07-19T04:00:00Z 2021-09-18T03:59:59Z 2021-08-05T20:00:36Z 2021-15170 0 0 0900006484c01943

Links from other tables